----- Bank of America Merrill Lynch analyst Allen Lutz is jazzed on telemedicine, initiating his coverage of industry leader Teladoc Health with a Buy rating and a $65 price target, a 12% upside potential from where the stock closed on Wednesday.
In his note, Lutz highlighted the company’s online therapy brand, BetterHelp, as a potential “crown jewel.”
“Teladoc is well positioned to shift a portion of the 1.25 [billion] annual doctor visits to its platform, in our view,” Lutz wrote. “The company is also aggressively pursuing a role in both the behavioral health and expert opinion markets, opportunities the company has sized at $12 [billion] and $28 [billion], respectively.” https://www.barrons.com/articles/teladoc-stock-betterhealth-online-therapy-brand-buy-rating-51560433939
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.